Home › Companies › FATE THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and FATE THERAPEUTICS INC.’s Form 8-K, filed 2024-06-07 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore FATE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are FATE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-07 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: William H. Rastetter, Ph.D. | 82,587,977 | -- | -- | 8,440,527 | 7,162,328 | Majority: yes |
| Elect Director: Michael Lee | 90,262,212 | -- | -- | 1,188,429 | 6,740,191 | Majority: yes |
| Elect Director: Yuan Xi, Ph.D. | 89,732,567 | -- | -- | 1,718,074 | 6,740,191 | Majority: yes |
| (ii) Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 96,478,449 | 113,003 | 1,599,380 | -- | -- | Majority: yes |
| (iii) Non-binding Advisory Vote on Compensation of Named Executive Officers. | 65,401,635 | 25,615,148 | 433,964 | -- | 6,740,085 | Majority: yes |
| (v) Approval of the 2022 A&R Plan to increase the number of shares of common stock reserved for issuance thereunder. | 59,762,463 | 31,270,315 | 417,969 | -- | 6,740,085 | Majority: yes |
| (vi) Approval of the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals. | 57,506,789 | 33,547,222 | 396,736 | -- | 6,740,085 | Majority: yes |
Source: FATE THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-07 — read the filing on EDGAR.
Each item below shows how the 198 asset managers that disclosed a FATE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of FATE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
FATE THERAPEUTICS INC.’s own tally for this item (“(iii) Non-binding Advisory Vote on Compensation of Named Executive Officers.”): 65,401,635 for, 25,615,148 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,798,942 outstanding shares: 57% for, 23% against (80% of the company cast a for/against vote).
The 192 asset managers below cast 74% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Redmile Group, LLC | 13,169,057 | 0 | 0 | 0 | For |
| State Street | 12,905,672 | 185,232 | 0 | 0 | For |
| Vanguard | 9,746,311 | 51,000 | 0 | 0 | For |
| BlackRock | 5,441,042 | 31,116 | 0 | 0 | For |
| Deep Track Capital, LP | 5,331,578 | 0 | 0 | 0 | For |
| Bellevue Group AG | 0 | 4,839,779 | 0 | 0 | Against |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,098,500 | 0 | 0 | 0 | For |
| DE Shaw | 0 | 2,261,602 | 0 | 0 | Against |
| Fidelity | 1,693,538 | 518,690 | 0 | 0 | For |
| Federated Hermes | 1,944,987 | 0 | 0 | 0 | For |
| Charles Schwab | 1,921,772 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,805,306 | 0 | 0 | 0 | For |
| Woodline Partners LP | 1,726,686 | 0 | 0 | 0 | For |
| Citadel | 1,687,757 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,627,759 | 0 | 0 | Against |
| ORBIMED ADVISORS LLC | 1,301,162 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 1,201,667 | 0 | 0 | Against |
| Two Sigma | 0 | 1,186,681 | 0 | 0 | Against |
| Point72 | 0 | 1,107,330 | 0 | 0 | Against |
| Holocene Advisors, LP | 0 | 1,075,781 | 0 | 0 | Against |
| JPMorgan | 0 | 896,905 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 800,000 | 0 | 0 | Against |
| Victory Capital | 0 | 698,494 | 0 | 0 | Against |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 665,307 | 0 | 0 | Against |
Showing the 25 largest of 192 asset managers. See all 192 in the interactive database.
Combines 3 wordings of this item as funds reported it.
66% Majority: yes · of votes cast
FATE THERAPEUTICS INC.’s own tally for this item (“(v) Approval of the 2022 A&R Plan to increase the number of shares of common stock reserved for issuance thereunder.”): 59,762,463 for, 31,270,315 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,798,942 outstanding shares: 52.5% for, 27% against (80% of the company cast a for/against vote).
The 64 asset managers below cast 62% of the shares they voted on this item FOR (16,763,054 for, 10,107,654 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,355,861 | 51,000 | 0 | 0 | For |
| State Street | 65,053 | 5,915,398 | 0 | 0 | Against |
| Fidelity | 1,693,538 | 259,109 | 0 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 617,951 | 0 | 0 | Against |
| JPMorgan | 0 | 559,857 | 0 | 0 | Against |
| Victory Capital | 0 | 338,122 | 0 | 0 | Against |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 278,508 | 0 | 0 | Against |
| Nationwide | 1,315 | 236,109 | 0 | 0 | Against |
| Equitable | 232,470 | 4,800 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 236,948 | 0 | 0 | Against |
| Brighthouse | 0 | 181,254 | 35,418 | 0 | Against |
| AIG/SunAmerica | 0 | 215,412 | 0 | 0 | Against |
| Goldman Sachs | 0 | 195,010 | 0 | 0 | Against |
| MFS | 0 | 161,313 | 0 | 0 | Against |
| T. Rowe Price | 0 | 157,978 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 0 | 135,406 | 0 | 0 | Against |
| ProShares | 0 | 120,872 | 0 | 0 | Against |
| Putnam | 0 | 118,215 | 0 | 0 | Against |
Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
FATE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Lee”): 90,262,212 for, 1,188,429 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,798,942 outstanding shares: 79% for, 1% withheld (80% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (26,563,963 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,966,054 | 0 | 14,397 | 0 | For |
| Fidelity | 1,717,438 | 0 | 235,209 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 136,890 | 0 | 100,380 | 0 | For |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| Brighthouse | 181,254 | 0 | 35,418 | 0 | For |
| AIG/SunAmerica | 215,412 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
FATE THERAPEUTICS INC.’s own tally for this item (“Elect Director: William H. Rastetter, Ph.D.”): 82,587,977 for, 8,440,527 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,798,942 outstanding shares: 73% for, 7% withheld (80% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (20,381,803 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 127,836 | 0 | 5,852,615 | 0 | Abstain |
| Fidelity | 1,717,438 | 0 | 235,209 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 136,890 | 0 | 100,380 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 236,948 | 0 | Abstain |
| Brighthouse | 181,254 | 0 | 35,418 | 0 | For |
| AIG/SunAmerica | 215,412 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% fund support · no official result
The 63 asset managers below cast 97% of the shares they voted on this item FOR (26,036,836 for, 877,113 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,970,117 | 10,334 | 0 | 0 | For |
| Fidelity | 1,952,647 | 0 | 0 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 559,857 | 0 | 0 | Against |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 236,109 | 1,315 | 0 | 0 | For |
| Equitable | 237,270 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| Brighthouse | 23,823 | 157,431 | 35,418 | 0 | Against |
| AIG/SunAmerica | 215,412 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 2 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
FATE THERAPEUTICS INC.’s own tally for this item (“(vi) Approval of the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals.”): 57,506,789 for, 33,547,222 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,798,942 outstanding shares: 50.5% for, 29% against (80% of the company cast a for/against vote).
The 63 asset managers below cast 61% of the shares they voted on this item FOR (16,392,183 for, 10,521,766 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,355,861 | 51,000 | 0 | 0 | For |
| State Street | 65,053 | 5,915,398 | 0 | 0 | Against |
| Fidelity | 1,693,538 | 259,109 | 0 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 0 | 800,607 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 617,951 | 0 | 0 | Against |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 338,122 | 0 | 0 | Against |
| TIAA | 0 | 293,883 | 0 | 0 | Against |
| Dimensional | 0 | 278,508 | 0 | 0 | Against |
| Nationwide | 0 | 237,424 | 0 | 0 | Against |
| Equitable | 232,470 | 4,800 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 236,948 | 0 | 0 | Against |
| Brighthouse | 157,431 | 23,823 | 35,418 | 0 | For |
| AIG/SunAmerica | 0 | 215,412 | 0 | 0 | Against |
| Goldman Sachs | 0 | 195,010 | 0 | 0 | Against |
| MFS | 0 | 161,313 | 0 | 0 | Against |
| T. Rowe Price | 0 | 157,978 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 0 | 135,406 | 0 | 0 | Against |
| ProShares | 0 | 120,872 | 0 | 0 | Against |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
FATE THERAPEUTICS INC.’s own tally for this item (“(ii) Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 96,478,449 for, 113,003 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,798,942 outstanding shares: 85% for, 0.1% against (85% of the company cast a for/against vote).
The 63 asset managers below cast 99.9% of the shares they voted on this item FOR (26,903,311 for, 10,638 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,970,117 | 10,334 | 0 | 0 | For |
| Fidelity | 1,952,647 | 0 | 0 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 237,270 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| Brighthouse | 181,254 | 0 | 35,418 | 0 | For |
| AIG/SunAmerica | 215,412 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 62 asset managers below cast 100% of the shares they voted on this item FOR (26,259,453 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,966,054 | 0 | 14,397 | 0 | For |
| Fidelity | 1,717,438 | 0 | 235,209 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 278,508 | 0 | Abstain |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 136,890 | 0 | 100,380 | 0 | For |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| Brighthouse | 181,254 | 0 | 35,418 | 0 | For |
| AIG/SunAmerica | 215,412 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 3 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
FATE THERAPEUTICS INC.’s own tally for this item (“(iii) Non-binding Advisory Vote on Compensation of Named Executive Officers.”): 65,401,635 for, 25,615,148 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,798,942 outstanding shares: 57% for, 23% against (80% of the company cast a for/against vote).
The 5 asset managers below cast 0.4% of the shares they voted on this item FOR (13,341 for, 3,353,083 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 2,140,000 | 0 | 0 | Against |
| JPMorgan | 0 | 1,213,083 | 0 | 0 | Against |
| ALGERT GLOBAL LLC | 13,331 | 0 | 0 | 0 | For |
| Lido Advisors, LLC | 10 | 0 | 0 | 0 | For |
| IPConcept (Luxemburg) S.A. | 0 | 0 | 0 | 0 | -- |
Ranked by the number of FATE THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 113,798,942 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Redmile Group, LLC | 11.57% |
| 2 | State Street | 11.50% |
| 3 | Vanguard | 8.61% |
| 4 | BlackRock | 4.81% |
| 5 | Deep Track Capital, LP | 4.69% |
| 6 | Bellevue Group AG | 4.25% |
| 7 | Johnson & Johnson Innovation - JJDC, Inc. | 2.97% |
| 8 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.72% |
| 9 | DE Shaw | 1.99% |
| 10 | Fidelity | 1.94% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with Redmile Group, LLC | 11.57% | DEF14A |
| BlackRock | 9.39% | 13F |
| ARK Investment Management LLC | 9.06% | DEF14A |
| Vanguard Group | 7.73% | 13F |
| State Street | 7.06% | 13F |
| Boxer Capital, LLC | 5.42% | DEF14A |
| Citadel Advisors | 2.77% | 13F |
| D.E. Shaw | 2.40% | 13F |
| Geode Capital | 1.67% | 13F |
| Point72 | 1.39% | 13F |
Percentages above are of 113,798,942 shares outstanding, as reported by FATE THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FATE THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At FATE THERAPEUTICS INC.'s shareholder meeting held 2024-06-07, in the 2023-2024 proxy season, 198 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,772 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 72% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: FATE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-07.
FATE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.